HomeCompareTCBP vs BTI

TCBP vs BTI: Dividend Comparison 2026

TCBP yields 400.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCBP wins by $11437.79M in total portfolio value
10 years
TCBP
TCBP
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full TCBP calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TCBP vs BTI

📍 TCBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCBPBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCBP + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCBP pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCBP
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, TCBP beats the other by $6,517,111,424.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCBP + BTI for your $10,000?

TCBP: 50%BTI: 50%
100% BTI50/50100% TCBP
Portfolio after 10yr
$5718.93M
Annual income
$3,833,597,742.20/yr
Blended yield
67.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TCBP
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-14.7
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCBP buys
0
BTI buys
0
No recent congressional trades found for TCBP or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCBPBTI
Forward yield400.00%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$11437.82M$37.7K
Annual income after 10y$7,667,192,697.76$2,786.64
Total dividends collected$11090.87M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: TCBP vs BTI ($10,000, DRIP)

YearTCBP PortfolioTCBP Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$50,700$40,000.00$11,299$598.92+$39.4KTCBP
2$243,782$189,532.71$12,794$703.91+$231.0KTCBP
3$1,112,560$851,713.55$14,518$829.07+$1.10MTCBP
4$4,823,161$3,632,721.39$16,513$978.64+$4.81MTCBP
5$19,879,046$14,718,264.42$18,827$1,157.84+$19.86MTCBP
6$77,964,520$56,693,940.88$21,518$1,373.12+$77.94MTCBP
7$291,226,244$207,804,207.46$24,657$1,632.46+$291.20MTCBP
8$1,037,056,355$725,444,273.70$28,329$1,945.74+$1037.03MTCBP
9$3,523,955,262$2,414,304,962.28$32,637$2,325.33+$3523.92MTCBP
10$11,437,824,828$7,667,192,697.76$37,708$2,786.64+$11437.79MTCBP

TCBP vs BTI: Complete Analysis 2026

TCBPStock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Full TCBP Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TCBP vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCBP vs SCHDTCBP vs JEPITCBP vs OTCBP vs KOTCBP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.